COVID-19 vaccine, developed by the University of Oxford, in India.Known as AZD1222, the vaccine candidate has been made by the Jenner Institute, a part of the Nuffield Department of Medicine at the University of Oxford.
The formulation is backed by by AstraZeneca PLC, a British-Swedish pharmaceutical company. AstraZeneca has joined hands with Serum Institute of India to produce the potential vaccine.According to a report by news agency Press Trust of India (PTI), Adar Poonawalla led drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of the vaccine candidate.
The company will launch the vaccine under the brand name of Covishield if the trials are successful.Around 1,600 participants will.